Company profile: Ipsen
1.1 - Company Overview
Company description
- Provider of specialty-driven biopharmaceutical therapies, developing and commercializing innovative medicines in oncology, neuroscience, and rare disease. Offers treatments for cancer (including prostate cancer), neurological conditions, and rare diseases; invests in R&D and conducts clinical trials to evaluate safety and efficacy and advance new therapeutic solutions.
Products and services
- Oncology: Ipsen develops specialty-driven cancer therapies addressing unmet medical needs, with an expanding portfolio of key treatments for prostate cancer
- Neuroscience: Ipsen offers research-driven therapies for neurological conditions, leveraging research to address complex disorders in neuroscience and support specialty care
- Rare Disease: Ipsen produces specialty-care therapies for rare diseases, aiming to improve patient outcomes through specialized therapies across uncommon conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ipsen
mdgroup
HQ: United Kingdom
Website
- Description: Provider of professional services to a wide range of industries, with a focus in the life sciences sector. Women-owned, independent global organisation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full mdgroup company profile →
Berkshire Sterile Manufacturing
HQ: United States
Website
- Description: Provider of small-scale sterile manufacturing services for clinical use, delivering the safest sterile drug products with the highest level of sterility assurance and quality through modern sterile manufacturing technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berkshire Sterile Manufacturing company profile →
Concept Life Sciences
HQ: United Kingdom
Website
- Description: Provider of scientific laboratory and consulting services, offering integrated drug discovery and development; molecular biology (gene expression analysis, transcriptomics, genetic modification); protein production; spatial and structural biology; ADME & DMPK assays; and analytical testing and environmental consulting for pharmaceutical, biotechnology, agrochemical, and environmental sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concept Life Sciences company profile →
iCardiac
HQ: United States
Website
- Description: Provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iCardiac company profile →
Putnam Associates
HQ: United States
Website
- Description: Provider of strategic consulting and analytical services to biopharmaceutical, diagnostics, and medical device clients, supporting decisions across the product and franchise lifecycle. Offerings include Commercial Strategy; Value, Pricing & Access; Medical & Scientific Affairs; Financial Modelling & Forecasting; Integrated Insights; and Advanced Clinical Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Putnam Associates company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ipsen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ipsen
2.2 - Growth funds investing in similar companies to Ipsen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ipsen
4.2 - Public trading comparable groups for Ipsen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →